LUXI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.039
EU - Europa 884
AS - Asia 717
SA - Sud America 102
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 61
OC - Oceania 1
Totale 2.866
Nazione #
US - Stati Uniti d'America 964
RU - Federazione Russa 499
SG - Singapore 356
IT - Italia 159
CN - Cina 104
HK - Hong Kong 75
VN - Vietnam 75
BR - Brasile 74
CA - Canada 59
GB - Regno Unito 51
DE - Germania 37
FR - Francia 28
FI - Finlandia 27
IN - India 27
KR - Corea 23
IE - Irlanda 18
SE - Svezia 18
BJ - Benin 14
BD - Bangladesh 13
NG - Nigeria 12
TG - Togo 12
ZA - Sudafrica 12
AR - Argentina 10
NL - Olanda 10
AT - Austria 9
JP - Giappone 9
MX - Messico 8
PL - Polonia 8
TR - Turchia 7
ES - Italia 6
CL - Cile 4
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CO - Colombia 3
UA - Ucraina 3
UZ - Uzbekistan 3
EG - Egitto 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AD - Andorra 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
VE - Venezuela 1
YE - Yemen 1
Totale 2.804
Città #
Singapore 231
Dallas 221
Moscow 166
Ashburn 157
San Jose 131
Verona 76
Hong Kong 74
Chandler 40
Council Bluffs 37
Los Angeles 33
Ho Chi Minh City 28
Toronto 26
Beijing 23
New York 22
The Dalles 22
London 19
Helsinki 17
Dublin 16
Cotonou 14
São Paulo 14
Hamilton 13
Buffalo 12
Lomé 12
Abuja 11
Hanoi 11
Johannesburg 11
Montreal 11
Phoenix 11
Santa Clara 11
Seattle 10
Amsterdam 9
Catania 9
Tokyo 9
Boardman 8
Chennai 8
Da Nang 8
Orem 8
Poplar 8
Rome 8
Hyderabad 7
Boydton 6
Redondo Beach 6
Seoul 6
Chions 5
Columbus 5
Denver 5
Falkenstein 5
Misterbianco 5
Munich 5
Nuremberg 5
Southend 5
Stockholm 5
Warsaw 5
Ankara 4
Atlanta 4
Chicago 4
Lawrence 4
Madrid 4
Milan 4
Monserrato 4
Mumbai 4
North Bergen 4
Princeton 4
Redmond 4
Bonavigo 3
Brooklyn 3
Frankfurt am Main 3
Guangzhou 3
Jakarta 3
Lappeenranta 3
Mexico City 3
Milford 3
Palermo 3
Piscataway 3
Roubaix 3
Sindelfingen 3
Tashkent 3
Turku 3
Vicenza 3
Vienna 3
Washington 3
Wroclaw 3
Baghdad 2
Belo Horizonte 2
Bengaluru 2
Campo Grande 2
Cernusco sul Naviglio 2
Columbia 2
Concord 2
Darmstadt 2
Dhaka 2
Fernandina Beach 2
Graz 2
Greenville 2
Haiphong 2
Houston 2
Hải Dương 2
Kuala Lumpur 2
Kyiv 2
La Paz 2
Totale 1.764
Nome #
Safety Profile of Antiviral Therapies for the Early Treatment/Prevention of COVID-19: Analysis of the International Pharmacovigilance Database VigiBase 228
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 205
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 201
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBase 148
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy 141
Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies 139
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 139
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System 136
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study 134
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 134
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study 128
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study 127
Anaphylaxis due to antiallergic and antiasthmatic biologics 120
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database 118
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports 112
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study 107
Terapia immunosoppressiva di mantenimento nei pazienti sottoposti a trapianto di organo solido: survey delle esperienze dai centri-trapianto italiani 106
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study 106
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase® 100
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose 85
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group” 83
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women 36
Monitoraggio della sicurezza dei vaccini COVID-19 in popolazioni speciali attraverso sistemi di farmacovigilanza attiva: risultati del progetto europeo Covid-Vaccine-Monitor 18
Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase 8
Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study 7
Totale 2.866
Categoria #
all - tutte 9.863
article - articoli 9.391
book - libri 0
conference - conferenze 335
curatela - curatele 0
other - altro 137
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 7 0 2 13 2 2 1 1 0 2 14
2022/2023142 14 14 6 23 2 24 0 12 15 5 20 7
2023/2024171 4 21 13 12 13 22 10 11 7 24 17 17
2024/2025506 30 14 47 85 21 33 15 16 81 41 51 72
2025/20261.903 92 169 172 309 485 116 196 105 87 116 30 26
2026/2027100 40 60 0 0 0 0 0 0 0 0 0 0
Totale 2.866